Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-20

Clinical Trial Update: Lofexidine for Inpatient Opiate Detox [Phase 3]

View source ↗

Summary

A Phase 3 trial of lofexidine for inpatient detoxification in opioid use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOFEXIDINE (LOFEXIDINE)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Opiate Addiction | Phase 3 | Status: COMPLETED